Latest news
Ziphius Appoints Trudy Vanhove as Non-Executive Director and Announces New York Office Opening
May 31, 2024
Ziphius, a leading biotechnology company developing self-amplifying RNA (saRNA) vaccines and therapeutics, is excited to announce the appointment of Trudy Vanhove, MD, PhD, MBA as Non-Executive Director. Additionally, the Company announces the opening of its New York office at the Genome Center located at 101 Avenue of the Americas.